Leptospira borgpetersenii hybrid leucine-rich repeat protein: Cloning and expression, immunogenic identification and molecular docking evaluation
Tài liệu tham khảo
Adler, 2010, Leptospira and leptospirosis, Vet. Microbiol., 140, 287, 10.1016/j.vetmic.2009.03.012
Azad, 2013, In Silico analysis of outer membrane protein 31 Brucella spp. to identifiy and characterize the potential T cell epitope, Int. J. Pharm. Med. & Bio. Sc., 2, 28
Backert, 2015, Immunoinformatics and epitope prediction in the age of genomic medicine, Genome Med., 7, 119, 10.1186/s13073-015-0245-0
Branger, 2001, Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination, Infect. Immun., 69, 6831, 10.1128/IAI.69.11.6831-6838.2001
Calis, 2013, Properties of MHC class I presented peptides that enhance immunogenicity, PLoS Comput. Biol., 9, 10.1371/journal.pcbi.1003266
Chen, 2003, A novel shape complementarity scoring function for protein-protein docking, Proteins, 51, 397, 10.1002/prot.10334
Deveson Lucas, 2011, Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model, Vaccine, 29, 3413, 10.1016/j.vaccine.2011.02.084
Forster, 2013, A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis, Clin. Vaccine Immunol., 20, 725, 10.1128/CVI.00601-12
Gebriel, 2006, The detection and characterization of pathogenic Leptospira and the use of OMPs as potential antigens and immunogens, Trop. Biomed., 23, 194
Gonzalez-Galarza, 2015, Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations, Nucleic Acids Res., 43, D784, 10.1093/nar/gku1166
Haake, 2000, The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection, Infect. Immun., 68, 2276, 10.1128/IAI.68.4.2276-2285.2000
Hartwig, 2010, High yield expression of leptospirosis vaccine candidates LigA and LipL32 in the methylotrophic yeast Pichia pastoris, Microb. Cell Factories, 9, 98, 10.1186/1475-2859-9-98
Hinjoy, 2001, 74
Hniman, 2007, Development of Leptospira molecular markers by using bioinformation from predicted leucine-rich repeat (LRR) protein genes, J. Thai Vet. Med. Assoc., 58, 65
Ikegami, 2004, Multiple functions of the leucine-rich repeat protein LrrA of Treponema denticola, Infect. Immun., 72, 4619, 10.1128/IAI.72.8.4619-4627.2004
Kobe, 2001, The leucine-rich repeat as a protein recognition motif, Curr. Opin. Struct. Biol., 11, 725, 10.1016/S0959-440X(01)00266-4
Koizumi, 2003, Molecular cloning and characterization of a novel leptospiral lipoprotein with OmpA domain, FEMS Microbiol. Lett., 226, 215, 10.1016/S0378-1097(03)00619-0
LaRock, 2012, The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing, Cell Host Microbe, 12, 799, 10.1016/j.chom.2012.10.020
Li, 2003, RDOCK: refinement of rigid-body protein docking predictions, Proteins, 53, 693, 10.1002/prot.10460
Li, 2005, Identification of genes required for avian Escherichia coli septicemia by signature-tagged mutagenesis, Infect. Immun., 73, 2818, 10.1128/IAI.73.5.2818-2827.2005
Lovell, 2003, Structure validation by Calpha geometry: phi, psi and C beta deviation, Proteins, 50, 437, 10.1002/prot.10286
McCoy, 2010, The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence, Infect. Immun., 78, 2584, 10.1128/IAI.00141-10
McDonald, 2003, The Yersinia virulence factor YopM forms a novel protein complex with two cellular kinases, J. Biol. Chem., 278, 18514, 10.1074/jbc.M301226200
Nitipan, 2013, Examining putative leucine-rich repeat LBJ_2271 ortholog genes in Leptospira borgpetersenii serovar Sejroe genome, KKU. Vet J., 23, 1
Nitipan, 2013, Identification of epitopes in Leptospira borgpetersenii leucine-rich repeat proteins, Infect. Genet. Evol., 14, 46, 10.1016/j.meegid.2012.10.014
Palaniappan, 2006, Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection, Infect. Immun., 74, 1745, 10.1128/IAI.74.3.1745-1750.2006
Prapong, 2003, O33
Ren, 2003, Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing, Nature, 422, 888, 10.1038/nature01597
Sabet, 2005, LPXTG protein InlJ, a newly identified internalin involved in Listeria monocytogenes virulence, Infect. Immun., 73, 6912, 10.1128/IAI.73.10.6912-6922.2005
Sawyer, 1996, Internalin A can mediate phagocytosis of Listeria monocytogenes by mouse macrophage cell lines, J. Leukoc. Biol., 60, 603, 10.1002/jlb.60.5.603
Seepersaud, 2005, Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity, Infect. Immun., 73, 1671, 10.1128/IAI.73.3.1671-1683.2005
Seixas, 2007, Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis, Can. J. Microbiol., 53, 472, 10.1139/w06-138
Silva, 2007, The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis, Vaccine, 25, 6277, 10.1016/j.vaccine.2007.05.053
Tamura, 2013, MEGA6: molecular evolutionary genetics analysis version 6.0, Mol. Biol. Evol., 30, 2725, 10.1093/molbev/mst197
Ye, 2009, Gr1+ cells control growth of YopM-negative Yersinia pestis during systemic plague, Infect. Immun., 77, 3791, 10.1128/IAI.00284-09
Zhang, 2013, A combination of epitope prediction and molecular docking allows for good identification of MHC class I restricted T-cell epitopes, Comput. Biol. Chem., 45, 30, 10.1016/j.compbiolchem.2013.03.003